A

Adlai Nortye Ltd
D

ANL

8.99000
USD
-0.01
(-0.11%)
مغلق
حجم التداول
4,842
الربح لكل سهم
-1
العائد الربحي
-
P/E
-8
حجم السوق
328,781,388
المقالات

العنوان: Adlai Nortye Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.